Valuation: Ipca Laboratories Limited

Market Cap 493B 5.24B 4.7B 4.3B 3.92B 7.39B 7.62B 51.78B 20.65B 263B 19.67B 19.25B 830B P/E 2027 *
32.5x
P/E 2028 * 27.6x
Enterprise Value 482B 5.13B 4.6B 4.2B 3.84B 7.23B 7.46B 50.66B 20.2B 257B 19.25B 18.83B 812B EV / Sales 2027 *
4.39x
EV / Sales 2028 * 3.85x
Free-Float
54.94%
Yield 2027 *
0.3%
Yield 2028 * 0.32%
1 day-0.40%
1 week+0.81%
Current month+0.73%
1 month-0.49%
3 months+10.02%
6 months+25.94%
Current year+36.85%
1 week 1,891.2
Extreme 1891.2
2,012
1 month 1,797
Extreme 1797
2,012
Current year 1,391.8
Extreme 1391.8
2,038
1 year 1,276.1
Extreme 1276.1
2,038
3 years 984.35
Extreme 984.35
2,038
5 years 669.8
Extreme 669.8
2,038
10 years 200
Extreme 200
2,038
Manager TitleAgeSince
Chief Executive Officer 53 31/03/2023
Chief Executive Officer 70 31/03/2023
Chief Tech/Sci/R&D Officer 52 15/10/2023
Director TitleAgeSince
Chairman 79 04/07/2012
Director/Board Member 53 10/11/2008
Director/Board Member 70 31/07/1994
Date Insider Type Main position Quantity % Market Cap. Importance
19/12/24 Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
-0.40%+0.81%+49.97%+100.23% 5.23B
-0.79%-1.43%+46.25%+138.46% 1,216B
+1.43%+0.37%+48.51%+82.52% 656B
+1.07%+0.18%+34.39%+105.99% 509B
-0.36%-2.84%+47.23%+64.51% 384B
-0.14%+0.27%+73.87%+41.93% 362B
-0.78%+0.59%+31.01%+59.68% 311B
-0.80%+6.73%+11.89%+35.64% 293B
+0.03%-0.07%+43.94%+70.61% 249B
-0.41%+0.77%+36.15%+104.55% 208B
Average -0.12%+0.66%+42.32%+80.41% 419.3B
Weighted average by Cap. -0.05%+0.04%+43.47%+91.87%

Financials

2027 *2028 *
Net sales 110B 1.17B 1.05B 958M 875M 1.65B 1.7B 11.55B 4.61B 58.64B 4.39B 4.29B 185B 123B 1.31B 1.17B 1.07B 977M 1.84B 1.9B 12.9B 5.14B 65.48B 4.9B 4.79B 207B
Net income 15.12B 161M 144M 132M 120M 227M 234M 1.59B 634M 8.07B 604M 591M 25.47B 17.9B 190M 171M 156M 142M 268M 277M 1.88B 750M 9.55B 715M 699M 30.15B
Net Debt -10.65B -113M -102M -92.87M -84.77M -160M -165M -1.12B -446M -5.68B -425M -416M -17.94B -19.96B -212M -190M -174M -159M -299M -309M -2.1B -836M -10.65B -797M -780M -33.62B
Projected Income Statement - Annual - Ipca Laboratories Limited
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
06/11/26 ₹1,941.80 -0.40% 237,888
05/11/26 ₹1,949.60 -1.14% 609,355
04/11/26 ₹1,972.00 +1.12% 402,858
03/11/26 ₹1,950.10 +0.01% 361,957
02/11/26 ₹1,949.90 +1.15% 213,868
Trader
Investor
Global
Quality
ESG MSCI
B
MarketScreener Ratings - Ipca Laboratories Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,941.80INR
Average target price
1,981.72INR
Spread / Average Target
+2.06%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Ipca Laboratories Limited
  1. Stock Market
  2. Stocks
  3. IPCALAB Stock